Cargando…
PROTACs for BRDs proteins in cancer therapy: a review
BRDs proteins that recognise chromatin acetylation regulate gene expression, are epigenetic readers and master transcription coactivators. BRDs proteins are now emerging as targets for new therapeutic development. Blocking the function of any of BRDs proteins can be a control agent for diseases, suc...
Autores principales: | Wang, Chao, Zhang, Yujing, Yang, Shanbo, Chen, Wujun, Xing, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225710/ https://www.ncbi.nlm.nih.gov/pubmed/35702740 http://dx.doi.org/10.1080/14756366.2022.2081164 |
Ejemplares similares
-
Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents
por: Wang, Chao, et al.
Publicado: (2022) -
Small Molecules Targeting HATs, HDACs, and BRDs in Cancer Therapy
por: Wu, Donglu, et al.
Publicado: (2020) -
Proteolysis-targeting chimaeras (PROTACs) as pharmacological tools and therapeutic agents: advances and future challenges
por: Wang, Chao, et al.
Publicado: (2022) -
P-TEFb as a target to reactivate latent HIV: Two Brds are now in hand
por: Rice, Andrew P.
Publicado: (2013) -
PROTAC-DB: an online database of PROTACs
por: Weng, Gaoqi, et al.
Publicado: (2020)